001     893880
005     20230217124531.0
024 7 _ |a 10.1111/ene.15005
|2 doi
024 7 _ |a 1351-5101
|2 ISSN
024 7 _ |a 1468-1331
|2 ISSN
024 7 _ |a 1471-0552
|2 ISSN
024 7 _ |a 2128/28505
|2 Handle
024 7 _ |a altmetric:108989839
|2 altmetric
024 7 _ |a pmid:34216082
|2 pmid
024 7 _ |a WOS:000675075100001
|2 WOS
037 _ _ |a FZJ-2021-02892
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schneider, Christian
|0 P:(DE-Juel1)158077
|b 0
245 _ _ |a Motor unit number estimation in adult patients with spinal muscular atrophy treated with nusinersen
260 _ _ |a Oxford
|c 2021
|b Blackwell Science
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2021-07-20
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2021-09-01
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2021-09-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1629097280_5910
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Background and purposeThe aim was to assess the organization and short-term changes of motor units in adult patients with spinal muscular atrophy (SMA) treated with nusinersen.MethodsIn this single-centre cross-sectional and longitudinal study 15 adult patients with SMA type 3 were assessed and compared to 15 age-matched healthy controls and nine patients with amyotrophic lateral sclerosis. Moreover, 10 patients with SMA were followed up after 4–8 months. All patients were investigated clinically and by the motor unit number estimation method MScanFit of the abductor pollicis brevis muscle.ResultsThe number of motor units (p < 0.001) was significantly lower in patients with SMA compared to healthy controls at study entry. Mean unit amplitude, median amplitude and largest unit (p < 0.001) were significantly increased in patients with SMA. Patients with amyotrophic lateral sclerosis showed a significant reduction of compound muscle action potential (p = 0.005) and number of motor units (p = 0.03) compared to patients with SMA, accompanied by a larger median amplitude (p = 0.03). A prospective analysis identified patients with the ability to walk to improve the number of motor units (p = 0.046) accompanied by a decreased median amplitude (p = 0.03). Electrophysiological measures showed a moderate to strong correlation with clinical scores.ConclusionPatients with SMA show loss of motor units in distal muscles. MScanFit variables indicate that compound muscle action potential amplitudes are maintained by collateral sprouting. Prospective analyses suggest that milder affected adult patients with SMA preferentially benefit from nusinersen treatment through recovery of smaller motor units. Correlations with clinical scores underline the potential of MScanFit as a surrogate marker.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
542 _ _ |i 2021-07-20
|2 Crossref
|u http://creativecommons.org/licenses/by-nc/4.0/
542 _ _ |i 2021-07-20
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Wassermann, Meike K.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Grether, Nicolai B.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 3
700 1 _ |a Wunderlich, Gilbert
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Lehmann, Helmar C.
|0 P:(DE-HGF)0
|b 5
|e Corresponding author
773 1 8 |a 10.1111/ene.15005
|b Wiley
|d 2021-07-20
|n 9
|p 3022-3029
|3 journal-article
|2 Crossref
|t European Journal of Neurology
|v 28
|y 2021
|x 1351-5101
773 _ _ |a 10.1111/ene.15005
|g p. ene.15005
|0 PERI:(DE-600)2020241-6
|n 9
|p 3022-3029
|t European journal of neurology
|v 28
|y 2021
|x 1351-5101
856 4 _ |u https://juser.fz-juelich.de/record/893880/files/ene.15005.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:893880
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NEUROL : 2015
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts
999 C 5 |a 10.1056/NEJMoa1702752
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1056/NEJMoa1710504
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S1474-4422(20)30037-5
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/mus.26304
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.clinph.2019.04.713
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.clinph.2020.01.018
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1080/146608200300079536
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Jacobsen AB
|y 2018
|2 Crossref
|o Jacobsen AB 2018
999 C 5 |a 10.1002/mus.24945
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.clinph.2013.07.016
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.3109/21678421.2012.732079
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.clinph.2017.03.045
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.nmd.2007.05.009
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1177/1756286420907803
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.3233/JND-190416
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1212/WNL.0000000000009914
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1136/jnnp-2020-324254
|9 -- missing cx lookup --
|2 Crossref


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21